Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19

• DOI: 10.1016/j.ijid.2021.09.070
• Publication Date: 2021-09-30T18:34:49Z
• Authors: Hiromu Tanaka; Ho Lee; Atsuho Morita; Ho Namkoong; Shotaro Chubachi; Hiroki Kabata; Hirofumi Kamata; Makoto Ishii; Naoki Hasegawa; Norihiro Harada; Tetsuya Ueda; Soichiro Ueda; Takashi Ishiguro; Ken Arimura; Fukuki Saito; Takashi Yoshiyama; Yasushi Nakano; Yoshikazu Mutoh; Yusuke Suzuki; Koji Murakami; Yukinori Okada; Ryuji Koike; Yuko Kitagawa; Katsushi Tokunaga; Akinori Kimura; Seiya Imoto; Satoru Miyano; Seishi Ogawa; Takanori Kanai; Koichi Fukunaga
• Keywords: 2019-20 coronavirus outbreak; Pandemic; Coronavirus; Task force; Baseline (sea); Betacoronavirus

The coronavirus disease (COVID-19) pandemic is having a devastating effect worldwide. Host genome differences between populations may influence the severity of COVID-19. Japan COVID-19 Task Force conducting host analysis hospitalized patients with from more than 70 institutions nationwide in Japan. This report describes clinical characteristics enrolled to date. median (interquartile range) age 1674 included was 59 (45-71) years, and half (66.2%) were male. Less (41.2%) had severe disease. case fatality rate 3.2%. Since this hospital-based study, number cases relatively high, but low, when compared that other countries. In future, we will continue enroll conduct analyses